
Vaccination efforts against COVID-19 are underway across the world. In the United States, two vaccines have been authorized by the Food and Drug Administration for use, one developed by Moderna and one by Pfizer-BioNTech. Limitations on the amount of available doses have led the Centers for Disease Control to provide recommendations on who should be vaccinated first, but eventually the general public will be able to receive the vaccine. Its widespread availability will naturally lead to questions for both the public and for policy makers on whether vaccination against COVID-19 will be a requirement to board a plane, return to school, attend a concert…